CIK 0001279704 · Non-accelerated filer<br>Smaller reporting company
Cellectar Biosciences, Inc.
Sign in to watch- Ticker
- CLRB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043321804
- Phone
- (608) 441-8120
- Business address
- 100 CAMPUS DRIVE, FLORHAM PARK, NJ, 07932
- Former names
- NOVELOS THERAPEUTICS, INC., COMMON HORIZONS INC
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- UPLOAD Other SEC-generated Letter
- S-1 Offering Registration Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Executive or director change
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Open-market buy Chief Operating Officer bought 8,680 shares at $2.88 ($24,998)
- 4 Open-market buy Chief Executive Officer bought 8,680 shares at $2.88 ($24,998)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Material agreement · Unregistered share sale · Other events
- 424B5 Offering Prospectus
Page 2 of 61 · 1,218 filings